Related references
Note: Only part of the references are listed.Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands
Giuseppe Romeo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Characterization of Sigma 1 Receptor Antagonist CM-304 and Its Analog, AZ-66: Novel Therapeutics Against Allodynia and Induced Pain
Thomas J. Cirino et al.
FRONTIERS IN PHARMACOLOGY (2019)
The Molecular Function of σ Receptors: Past, Present, and Future
Hayden R. Schmidt et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Benzimidazolone-based selective σ2 receptor ligands: Synthesis and pharmacological evaluation
Sebastiano Intagliata et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Divergent Cytotoxic and Metabolically Stimulative Functions of Sigma-2 Receptors: Structure-Activity Relationships of 6-Acetyl-3(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79) Derivativess
Hilary E. Nicholson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Potential applications for sigma receptor ligands in cancer diagnosis and therapy
Aren van Waarde et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
Effects of a Selective Sigma 1 Antagonist Compound on Inflammatory Pain
Carmela Parenti et al.
INFLAMMATION (2014)
The antagonistic effect of the sigma 1 receptor ligand (+)-MR200 on persistent pain induced by inflammation
Carmela Parenti et al.
INFLAMMATION RESEARCH (2014)
Sigma 1 receptor: A new therapeutic target for pain
Daniel Zamanillo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Effect of Resveratrol-Related Stilbenoids on Biomembrane Models
Maria Grazia Sarpietro et al.
JOURNAL OF NATURAL PRODUCTS (2013)
The Therapeutic Potential of Sigma (σ) Receptors for the Treatment of Central Nervous System Diseases: Evaluation of the Evidence
Samuel D. Banister et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Novel Potent and Selective σ Ligands: Evaluation of Their Agonist and Antagonist Properties
Agostino Marrazzo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Interaction of the chemopreventive agent resveratrol and its metabolite, piceatannol, with model membranes
Olga Wesolowska et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Molecular interactions of cord factor with dipalmitoylphosphatidylcholine monolayers: Implications for lung surfactant dysfunction in pulmonary tuberculosis
G. Chimote et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2008)
The influence of fatty acids on model cholesterol/phospholipid membranes
Katarzyna Hac-Wydro et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2007)
Anomalous behavior of amine oxide surfactants at the air/water interface
Laura Goracci et al.
LANGMUIR (2007)
Modulation of brainstem opiate analgesia in the rat by σ1 receptors:: A microinjection study
Jianfeng Mei et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
A DSC and Raman spectroscopy study on the effect of PAMAM dendrimer on DPPC model lipid membranes
Konstantinos Gardikis et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
In vivo evaluation of (+)-MR200 as a new selective sigma ligand modulating MOP, DOP and KOP supraspinal analgesia
A Marrazzo et al.
LIFE SCIENCES (2006)
Modern physicochemical research on Langmuir monolayers
P Dynarowicz-Latka et al.
ADVANCES IN COLLOID AND INTERFACE SCIENCE (2001)
Synthesis and pharmacological evaluation of potent and enantioselective σ1 and σ2 ligands
A Marrazzo et al.
FARMACO (2001)
A model for the lipid pretransition: Coupling of ripple formation with the chain-melting transition
T Heimburg
BIOPHYSICAL JOURNAL (2000)
Share Paper
